A new study introduces an innovative platform capable of accurately sizing the toxic repeat expansion mutations that drive muscular dystrophy, Huntington’s disease, and ALS.
Trending
- AI spending expected to top $1 trillion in 2 years. That estimate’s way too low if Jensen Huang’s right
- An AI trade involving energy and infrastructure that’s doubled your money, topping Nvidia
- Anthropic, Microsoft in talks for AI chip deal after $5 billion investment
- Pair arrested after boys abandoned by road in Portugal
- Azzi Fudd’s demise was greatly exaggerated
- SGA’s awkward Wemby answer about Isaiah Hartenstein’s defense confused everyone
- Michelle Wie West is designing her first golf course
- Browns coach Todd Monken already sounds exhausted by Browns QB competition
